• Dec 17, 2024

Australia Is New Bond Market Favorite for JPMorgan Asset Management

(Bloomberg) -- The great run in European government bonds is coming to an end, according to a portfolio manager at J.P. Morgan Asset Management, who is now betting Australia will be the next market to outperform.Most Read from BloombergHow California Sees the World, and ItselfLondon’s Tube Fares Are Set to Rise by 4.6% Next YearKim Crawford said there is little room for further gains in Europe compared to peers given swap markets are fairly pricing the amount of interest-rate cuts the European C

• Dec 17, 2024

CrowdStrike Stock Could Continue Recent Climb

CRWD has been on an uptrend since early August

• Dec 17, 2024

Fed Rate Cut Guidance Will Exceed Wall Street’s Bearish Outlook

The cost of borrowing money will likely continue to drop, underpinning riskier assets like bitcoin, says Scott Garliss.

• Dec 17, 2024

Watch These Nvidia Price Levels as Stock Slips Further Into Correction Territory

Shares Down 15% From Their November High

• Dec 17, 2024

Trump Serious About Bitcoin Reserve, Says MicroStrategy's Michael Saylor: 'Buy It Now And Own The Future'

MicroStrategy co-founder and executive chairman Michael Saylor said Monday that the incoming Donald Trump administration was serious about setting up a U.S. strategic Bitcoin (CRYPTO: BTC) reserve. What happened: During a CNBC interview, Saylor stressed the importance of "buying the future" if one knows where the money is going. "All the capital outside the U.S. and all the 20th-century antiquated capital is going to flow into digital assets and the Bitcoin network," the Bitcoin bull said. "The

• Dec 17, 2024

Equities Fall Intraday as Markets Weigh Macro Data

US benchmark equity indexes were lower intraday as the Federal Reserve kicked off its two-day moneta

• Dec 17, 2024

Housing market outlook: 14 forecasts for mortgage rates in 2025

‘ResiClub’ compiled both public and private mortgage rate forecasts for the end of 2025. Here’s where they predict rates will go.

• Dec 17, 2024

Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside

Cantor initiated coverage on Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company with five commercialized products. The company also collaborates with pharmaceutical companies to bring new molecules to market using its technologies, like PharmFilm. Aquestive is advancing a late-stage proprietary product candidate for severe allergic reactions, including anaphylaxis, and an earlier-stage epinephrine prodrug topical gel for various dermatology conditions. Cantor highlights that th

• Dec 17, 2024

Next U.S. Senate Banking Chair Calls Crypto 'Next Wonder' of World

Senator Tim Scott said the Senate will tackle crypto bills, and the incoming chair of the House Financial Services Committee said he hopes to pass them in 2025.

• Dec 17, 2024

Top Stock Movers Now: Amentum Holdings, Humana, Nvidia, and More

U.S. equities were lower in early afternoon trading, with the Dow Jones Industrial Average losing streak continuing and the Nasdaq falling from its record high yesterday.